Onyx Pharmaceuticals, Inc #pharmaceutical #market #size

Posted On Jan 21 2017 by

#onyx pharma # Welcome to the Onyx Pharmaceuticals, Inc. Shareholder Litigation Website This website has been established to provide general information regarding the Onyx Pharmaceuticals, Inc.(“Onyx”) Shareholder Litigation, pending in the Superior Court of California, County of San Mateo (the “Court”). The capitalized terms used on this website and not defined herein shall have the same meanings ascribed to them in the Order Granting Class Certification dated April 10, 2015. If you were a holder of Onyx common stock who received consideration for their shares in the Acquisition of Onyx by Amgen at the price of $125.00 per share who …


Company Profile #lupin #pharma

Posted On Jan 21 2017 by

#transtech pharma # vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines. vTv has a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The …


Onyx Pharma rejects Amgen s hostile bid #pharma #sales #job

Posted On Jan 21 2017 by

#onyx pharma # Onyx Pharmaceuticals, Inc confirmed that it has received and rejected an unsolicited proposal from Amgen Inc. to acquire all of Onyx’s outstanding shares and share equivalents for $120 per share in cash, subject to due diligence and other conditions. The Board of Directors of Onyx had evaluated the proposal made by Amgen with the assistance of its financial and legal advisors and concluded that the price proposed by Amgen significantly undervalued Onyx and its prospects, and was not in the best interest of Onyx or its shareholders. Onyx communicated this determination to Amgen on Friday, June 28, …


Amgen to Buy Onyx for $10 #pharmaceutical #industry #today

Posted On Jan 21 2017 by

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …


TransTech Pharma, Inc #med #pharma

Posted On Jan 21 2017 by

#transtech pharma # High Point, North Carolina (January 25, 2008) High Point, NC and Bagsvaerd, Denmark – January 25, 2008 – TransTech Pharma, Inc. and Novo Nordisk A/S announced today that TransTech has acquired all rights from Novo Nordisk to a portfolio of drug candidates being developed to treat metabolic disorders. This portfolio is comprised of three distinct therapeutic approaches to such treatment: H3 receptor antagonists, PPARd agonists, and 11βHSD1 inhibitors. After determining in January 2007 to focus all Novo Nordisk research and development resources on the company’s growing pipeline of protein-based pharmaceuticals, the company divested all existing preclinical and …


Pharmaceutical Procurement Jobs #bayer #pharma

Posted On Jan 21 2017 by

#jobs in pharmaceuticals # Pharmaceutical Procurement Jobs Every area of our business has a part to play in our life changing work, and Pharmaceutical Procurement is at the very forefront. Innovation is a way of life at AstraZeneca. It’s how we solve some of the most complex problems in medical science and how we constantly find better ways to meet patient needs. It’s also how we work together every day to nurture a working environment that champions the potential of everyone in our team. But in AstraZeneca we don’t have a monopoly on great ideas. That’s why in Procurement we …


Bayer Schering Pharma – Mirena Healthcare Professional information #pharma #marketing #news

Posted On Jan 21 2017 by

#bayer schering pharma # Bayer HealthCare Pharmaceuticals A History of Innovation in Birth Control Few advances have given women greater power over their lives than the Pill. When many people hear the name Bayer. they think of aspirin. And, in fact, Bayer s introduction of aspirin in 1899 was a major innovation. What many people don t realize is that Bayer HealthCare Pharmaceuticals (formerly Schering AG) is also the world s leading maker of hormonal contraceptives for women. What s more, the company has a long history of innovation in birth control stretching back almost to the introduction of the …


NPI Oman #pharma #equipment

Posted On Jan 21 2017 by

#pharmaceutical industries # Welcome to NPI National Pharmaceutical Industries Co. (SAOG) (NPI) is the first Pharmaceutical formulations manufacturing plant in Sultanate Of Oman. located in the Rusayl Industrial Estate, 10 Kms from Muscat International Air-port, Muscat, Sultanate of Oman. The Company is a landmark for this progressive nation, which has witnessed remarkable progress under the wise leadership of His Majesty Sultan Qaboos. Milestones Project Commissioned in 2001. Registered with Ministry of Health. Sultanate of Oman 2001. Registered under Unified GCC Scheme 2002. Registered in Kingdom of Saudi Arabia, UAE. Bahrain, Kuwait, Qatar, Jordan, Yemen Iraq 2002. Distributors appointed in all …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #pharma #solutions

Posted On Jan 21 2017 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


Recruiting Pharmaceutical Physicians: Only Medics #pharma #services

Posted On Jan 21 2017 by

#jobs in pharmaceuticals # Pharmaceutical Physician Jobs Recruiting Physicians for Pharma Only Medics is a specialist international medical recruitment company that focuses exclusively on the recruitment of pharmaceutical physicians for pharmaceutical companies, biotechnology companies, Clinical Research Organisations (CROs) and Regulatory Authorities. We successfully recruit on both a contingent and retained basis on permanent positions as well as interim medical assignments. Our geographic reach is truly global and although our main focus is the European job market, we also recruit for pharmaceutical physician jobs in the US, Canada, Australia and Asia Pacific. Created in 2005, Only Medics was the first of …